Patents expiring in 2034

US 8865880

Identification of a novel BHD gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2791134

CHEMISCHE VERBINDUNG ALS ZWISCHENPRODUKT ZUR HERSTELLUNG EINES CATECHOL-O-METHYLTRANSFERASE-INHIBITORS

BIAL PORTELA & Cª S A [PT] · Granted Wed Oct 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871199

Compositions and methods to promote implantation and engrafment of stem cells

REGENERATIVE SCIENCES, LLC · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871273

Method for producing granules

Takeda Pharmaceutical Company Limited · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871792

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871925

Compositions of novel carbohydrate drug for treatment of human diseases

GALECTIN THERAPEUTICS, INC. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871906

Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871191

Use of IL-15 preparations to treat lymphopenia

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871209

Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871206

Anti-human folate receptor beta antibodies and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871487

Compositions, methods and uses for inducing viral growth

Takeda Vaccines, Inc. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871447

Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence

The Regents of the University of California · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871766

Heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871774

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871905

Modification of CXCR4 using engineered zinc finger proteins

Sangamo Biosciences, Inc. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871789

Method of preventing or treating viral infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871810

Treating critically ill patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871902

Immunogenic POTE peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871794

Small-molecule agonists for type-2 orexin receptor

The Board of Regents of the University of Texas System · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871904

Processes and intermediates

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871907

Glycosylated immunoglobulin and immunoadhesin comprising the same

KOREA PRIME PHARM CO., LTD. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8871918

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2796145

EIN KOVALENTER KOMPLEX BESTEHEND AUS VON WILLEBRAND UND FAKTOR VIII VERBUNDEN MIT EINER DISULFIDBRÜCKE

CSL BEHRING GMBH [DE] · Granted Wed Oct 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877213

Live attenuated Leishmania vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877199

B cell surface reactive antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877161

GM1-like peptides and uses thereof

Georgia Regents Research Institute, Inc. · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877215

Compounds with modifying activity enhanced under hypoxic conditions

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877253

Cellular extracts

REGENICS AS · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877914

Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877195

Monoclonal antibodies to fibrin

The Regents of the University of California · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877718

Antiinfective and antitumoral compounds isolated from tropical lianas

Julius-Maximilians-Universitat Wurzburg · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877759

Aminopyrazines as ATR kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877797

Methods for treating Parkinson's disease using pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877765

Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877796

Spiro-oxindole MDM2 antagonists

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877917

Glycoconjugates of RNA interference agents

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8875970

Structure containing wound treatment material

Covidien LP · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877188

Detection and treatment of non-dermal fibrosis

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877206

Stimulation of an immune response by cationic lipids

PDS Biotechnology Corporation · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877208

Multivalent nanoemulsion vaccines

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877204

Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes

University of Connecticut Health Center · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877248

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877725

Peptide conjugated, inosine-substituted antisense oligomer compound and method

Sarepta Therapeutics, Inc. · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877726

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8877721

Small activating RNA molecules and methods of use

The Regents of the University of California · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8883155

Methods for treating hematopoietic malignancies

The Regents of the University of California · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8883840

Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8883771

Bivalent inhibitors of IAP proteins and therapeutic methods using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)